GlobeNewsWire
16 Jul 2026, 07:36 UTC · 10w ago
Verdict
Headline takes no side. We score CPRX +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 77% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Angelini Pharma has completed the acquisition of Catalyst Pharmaceuticals (CPRX).
More positive than 93% of claims this week
Blackstone is investing 1 billion euros in preferred equity to support the transaction.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 79% of claims this week
CDP Equity is investing approximately 1 billion euros to acquire a 23.5% stake in Angelini Pharma's common equity.
More positive than 66% of claims this week
The acquisition establishes Angelini Pharma's presence in the U.S. market and expands its brain health and rare disease platform.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 77% of ticker scores this week
The company was acquired by Angelini Pharma, expanding its reach and integrating into a larger global platform.
More positive than 62% of ticker scores this week
Blackstone is investing 1 billion euros in preferred equity as part of a strategic acquisition.
More positive than 51% of ticker scores this week
Morgan Stanley served as the sole financial advisor for the transaction.
More positive than 51% of ticker scores this week
The bank acted as the sole global coordinator and underwriter for the financing package.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
2h ago
—
CPRX hasn't traded since this ran. Last close $31.49 (Jul 15); the reaction starts at the next open.
CPRX chart →
